Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)

NCT02899169 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: Realgar-Indigo naturalis formula
DRUG: all-trans retinoic acid
DRUG: Arsenic trioxide
DRUG: Hydroxyurea

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Collaborators

[object Object]